Dynamic Technology Lab Private Ltd Acquires New Shares in Inari Medical, Inc. (NASDAQ:NARI)

Dynamic Technology Lab Private Ltd acquired a new stake in Inari Medical, Inc. (NASDAQ:NARI - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 33,869 shares of the company's stock, valued at approximately $1,397,000. Dynamic Technology Lab Private Ltd owned 0.06% of Inari Medical as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Algert Global LLC grew its position in shares of Inari Medical by 38.2% during the third quarter. Algert Global LLC now owns 44,106 shares of the company's stock worth $1,819,000 after buying an additional 12,180 shares in the last quarter. Cerity Partners LLC grew its holdings in Inari Medical by 2.8% during the 3rd quarter. Cerity Partners LLC now owns 24,056 shares of the company's stock worth $992,000 after acquiring an additional 652 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Inari Medical by 0.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 453,972 shares of the company's stock valued at $18,722,000 after purchasing an additional 1,783 shares in the last quarter. Landscape Capital Management L.L.C. purchased a new stake in shares of Inari Medical during the 3rd quarter worth $291,000. Finally, Intech Investment Management LLC acquired a new position in shares of Inari Medical during the third quarter worth $716,000. Institutional investors and hedge funds own 90.98% of the company's stock.

Analyst Ratings Changes

A number of research firms have weighed in on NARI. Truist Financial raised their price target on Inari Medical from $46.00 to $50.00 and gave the company a "hold" rating in a research note on Tuesday, October 29th. Canaccord Genuity Group raised their target price on Inari Medical from $71.00 to $74.00 and gave the stock a "buy" rating in a research report on Tuesday, October 29th. Stifel Nicolaus started coverage on Inari Medical in a report on Tuesday, September 17th. They issued a "hold" rating and a $50.00 price target for the company. Leerink Partnrs raised shares of Inari Medical to a "hold" rating in a report on Tuesday, September 3rd. Finally, Leerink Partners initiated coverage on shares of Inari Medical in a research report on Tuesday, September 3rd. They set a "market perform" rating and a $47.00 price objective for the company. Six investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $58.89.

Insider Activity

In related news, CFO Mitch C. Hill sold 3,000 shares of Inari Medical stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $45.13, for a total value of $135,390.00. Following the sale, the chief financial officer now directly owns 179,600 shares in the company, valued at $8,105,348. The trade was a 1.64 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director William Hoffman sold 40,000 shares of the stock in a transaction on Wednesday, October 16th. The stock was sold at an average price of $45.02, for a total value of $1,800,800.00. Following the completion of the transaction, the director now owns 601,233 shares of the company's stock, valued at $27,067,509.66. The trade was a 6.24 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 186,000 shares of company stock valued at $8,990,990 over the last quarter. Corporate insiders own 10.60% of the company's stock.

Inari Medical Stock Performance

NARI traded up $0.24 during trading on Wednesday, hitting $51.07. The stock had a trading volume of 193,087 shares, compared to its average volume of 981,785. The firm has a market capitalization of $2.99 billion, a P/E ratio of -37.65 and a beta of 0.96. Inari Medical, Inc. has a twelve month low of $36.73 and a twelve month high of $67.13. The company's 50-day moving average price is $45.86 and its 200 day moving average price is $47.43.

Inari Medical Profile

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.